Lu Han

Deep Learning Applications for the accurate identification of low-transcriptional activity drugs and their mechanism of actions.

Yongxiang Zhang, Zhiyong Xiao, Gang Liu, 2022, Pharmacological research.

LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent

Xiaorui Cheng, Yongxiang Zhang, Zhiyong Xiao, 2021, Brain Sciences.

Application of Network Pharmacology Based on Artificial Intelligence Algorithms in Drug Development

Wenxia Zhou, Xuejun Li, Lu Han, 2021, Network Pharmacology.

PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.

R. Ling, L. Yao, Ceshi Chen, 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

PC3T: a signature-driven predictor of chemical compounds for cellular transition

Yong Zhang, Xiuliang Cui, Yongxiang Zhang, 2023, Communications biology.

Inhibition of multiple SARS-CoV-2 variants entry by Lycium barbarum L. polysaccharides through disruption of spike protein-ACE2 interaction.

Yongxiang Zhang, Lu Han, Jingxuan Li, 2024, International journal of biological macromolecules.